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Purpose/Objective: The extended volume irradiation, in pelvis or 
para-aortic volumes, presents some technique and dosimetrical 
difficulties when performed with 3D-CRT due to the junction and the 
presence of critical upper abdominal structures. Compared with 3D-
CRT, Helical Tomotherapy (HT) delivers an highly conformal dose 
distribution with the possibility to treat extended fields (EF) without 
junctions. The aim of this work is to evaluate the EF technical 
feasibility and safety in Tomotherapy, to optimize the treatment 
planning parameters minimizing dose constraints. Dosimetrical data 
and early toxicities were evaluated. 
Materials and Methods: 31 patients, suitable to EF-IMRT for local 
disease and/or nodal disease on pelvic or lumbar-aortic area, were 
treated and analyzed. The prescription dose was 50.4/54 Gy (1.7-1.8 
Gy/die) for prophylactic lymph nodes (N-) and 60-66 Gy (2-2.2 Gy/die) 
for clinically evident gross disease in the pelvic or para-aortic chain 
(N+). The better parameters, in terms of modulation factor (MF), 
pitch and field width (FW) have been considered to optimize dose 
distribution and treatment time duration. DVH values were analysed 
in terms of D95, average dose for the PTVs and mean and maximum 
dose for OARs. The length of the treatment field, the N+ and N- 
volumes and the time of irradiation were also evaluated. The V5, V10, 
V15 of body was also calculated in order to evaluate the impact of low 
doses. To correlate the dose values to the safety of treatment, 
hematological, hepatic, renal and pancreatic functions were 
evaluated before, during and after treatment. Acute upper 
gastrointestinal (u-GI) and hematological toxicity were evaluated by 
RTOG scale. Hepatic, renal and pancreatic functions were evaluated 
by changes in serological parameters. 
Results: The mean FW, pitch, effective MF and gantry period were 2.5 
cm, 0.287, 1.8 and 13.5 s respectively. The average length of 
treatment was 31.7 cm. Mean irradiation was 10.8 minutes. Average 
values of D95% for PTVs was 96.5%, ranging between 94 and 98%. D95% of 
PTV N+ ranged between 55.1 and 67 Gy. Doses to OARs are reported in 
the table. The treatment was well tolerated, without schedule 
interruption. Ten patients (pts) experienced G1 GI toxicity and 3 pts 
G2 toxicity. Hematological toxicity was G1 in 6 pts, G2 in 4 pts (2 
received concomitant chemotherapy), G3 in 3 pts (all received 
concomitant chemotherapy). In 3 pts we observed a modest increase 
of pancreatic function and in 4 of liver function. There were no 
changes in renal function parameters. 
 
Conclusions: With our treatment design and dose schedule, we found 
that EF- IMRT by Tomotherapy could be safely with a good dose 
distribution and effectively delivered with minimal toxicity in the 
upper abdomen area.  
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Purpose/Objective: Prostate (P) is one of the treatment sites that is 
well suited for IMRT. However, radiation induced complications such 
as urinary incontinence and rectal bleeding are some of the side 
effects. The purpose of this study is to illustrate a protocol for P and P 
with seminal vesicles (P&SV) IMRT plan with step and shoot tecnique 
and Inverse Planning process (Pinnacle3 TPS) to conform the higher 
doses to target and to spare the more sensitive structures in the close 
proximity of the target. 
Materials and Methods: The PTV1 is the P CTV with the addition of 
1cm in all directions except 0.5 cm posteriorly.The PTV2 is the SV 
with the addition of the same margin and PTV1 removed from it. 
Rectum, femoral head, Bladder, anal canal are typical OARs. To force 
the dose distribution to better conform to the target, a shell ROI (1 
cm thick) is created around targets. To reduce high dose regions 
outside the target volumes the RVR ROI iscreated, which consists of 
external patient contour, 0.5 cm contracted, avoiding targets, shell 
and OARs. The isocenter is placed in the center of targets. Five 15 MV 
beams are used (gantry 180°, 255°, 325°, 35°, 105° and collimator 
0°,10°, 10°, 10°, 10°). The couch rotation is set at 0°. Using an odd 
number of beams makes it easier to avoid creating opposing beams. : 
The dose prescription for PTV1 is 74.25 Gy in 33 fr. (2.25 Gy single fr.) 
and for PTV2 is 62.04 Gy in 33 fr. (1.88 Gy). A SIB IMRT technique is 
used in P&SV plan. As a starting point the dose volume objectives, are 
used as in table.The objectives and objectives weights (relative 
importance) can be modified to obtain more satisfactory dose 
distributions. Each beam is optimized using DMPO (Direct Machine 
Parameter Optimization). The max number of iterations is 40, the 
maximum number of segments is 25 (P) or 35 (P&SV), the minimum 
segment area is 10 cm2(P) or 8cm2(P&SV). The final calculation of 
dose is performed with the Adaptive Convolve dose engine and 
0.2x0.2x0.2 cm3grid. 
 
 
Results: 10 (5 P, 5 P&SV) IMRT treatment plans were analyzed. The 
total mean D2%,D50% and D98% of PTV1 and PTV2 are (76.8 ± 0.9) Gy, 
(76.8 ± 0.9) Gy, (68.9 ± 2.0) Gy and (71.2 ± 0.6) Gy, (65.6 ± 1.4) Gy, 
(58.4 ± 1.9) Gy respectively. D50% of PTV2 is slightly larger because 
PTV2 is adjacent to PTV1. The total mean dose and HI of PTV1 and 
PTV2 are (74.1 ± 0.1) Gy, 0.11 ± 0.03 and (64.3 ±1.7) Gy, 0.20 ±0.02 
respectively. PTV2 HI are higher due to the proximity of rectum and 
PTV1. Small regions of high or low absorbed dose inside the target 
may develop when avoidance of neighboring sensitive structures is 
considered more important than high PTV dose homogeneity. Not only 
the required limits for OARs are respected but organ dose and 
expected toxicity are reduced. 
Conclusions: From the results obtained it can be said that the 
protocol of prostate IMRT plan with 'step and shoot' tecnique and 
Inverse Planning process is to be considered valid for increasing target 
dose and reducing toxicity in OARs.  
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Purpose/Objective: In volumetric modulated radiation therapy 
(VMAT) for Head and Neck (H&N) cancer, the dose distribution is 
complicated because of the large radiation field. Therefore the 
number of arc, collimator angle and the maximum leaf-speed are 
significant parameters for irradiating the radiation accurately. The 
purpose of our study is to ensure the influence of these parameters 
for reproducing dose distribution between treatment planning system 
(TPS) and actual dose in patient.  
Materials and Methods: Nineteen VMAT plans for third grade H&N 
cancers were created by Varian Eclipse TPS version.8.9. The 
prescription dose with 70 Gy per 35 fractions was adopted for all 
plans. The dose tolerance was based on RTOG0615. For comparison, 
the collimator angle and leaf-speed were changed for all plans by use 
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of TPS. The collimator angle was changed from 0 to 170 degree, the 
leaf-speed was changed from 2.0 to 4.0 cm/sec. Then these plans 
were delivered to phantom and verified with three-dimensional 
detector: Delta4 (ScandiDos). All plans were delivered with a Varian 
Clinac 21EX linear accelerator equipped with Millenium multi-leaf 
collimator (MLC). The MLC motion logs during VMAT delivery were 
acquired and analyzed. The dose distributions were evaluated if those 
plans were acceptable for RTOG0615 dose tolerance or not. 
Results: As results of the plan comparison with several collimator 
angle settings, a single arc plan with collimator angle of 45 degree 
was acceptable for RTOG0615. On the other hand, all double arc plans 
were acceptable for RTOG0615. As results of the dosimetric 
verification by use of Delta4 detector, the passing rate of gamma 
analysis for the double arc plan with collimator angle 15/345 degree 
was worst in all plans. As results of comparison with various leaf-
speeds, the passing rates of gamma analysis were worse in plans with 
leaf-speed of more than 3.5 cm/sec.  
 
 Figure 1. The plan for dosimetric veification using Delta4 detector was 
created by Varian Eclipse TPS. 
Conclusions: The number of arc and maximum leaf-speed were 
affective factors for accurate dose delivery in VMAT plans. On the 
other hand, the setting of collimator angle was less affective 
parameter than those factors.  
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Purpose/Objective: The feasibility of using the Vero system for 
radiosurgery is yet unexplored. The high mechanical stability of the 
machine, the non-coplanar O-ring rotation liberty and the volumetric 
on-board imaging capabilities imply its use for intracranial 
stereotactic treatments. The Vero SBRT system was benchmarked in a 
planning study against a Novalis SRS system for quality of delivered 
dose distributions to intracranial lesions. 
Materials and Methods: A total of 27 patients with one single brain 
lesion treated on the BrainLAB Novalis system, with 3mm leaf width 
MLC and C-arm gantry, were re-planned for BrainLAB Vero, with a 
5mm leaf width MLC mounted on an O-ring gantry allowing rotations 
around both the horizontal and vertical axis. The Novalis dynamic 
conformal arc (DCA) planning included vertex arcs, using 90° couch 
rotation. These vertex arcs cannot be reproduced with Vero due to 
the mechanical limitations of the O-ring gantry. Alternative class 
solutions were investigated for the Vero (Figure 1). Additionally, to 
distinguish between the effect of MLC leaf width and different beam 
arrangements on dose distributions, the Vero class solutions were also 
applied for Novalis. The added value of IMRT was also investigated in 
this study. Quality of the achieved dose distributions was expressed in 
the conformity index (CI) and gradient index (GI), and compared using 
a paired Student t-test with statistical significance for p-values ≤ 
0.05.
 
Results: For the larger lesions, volumes > 5cm3 no statistical 
significant difference in conformity was observed between Vero and 
Novalis. For smaller lesions, the dose distributions showed a 
significantly better conformity for the Novalis (ΔCI=13.74%, p=0.0002) 
mainly due to the smaller MLC leaf width. IMRT on Vero reduces this 
conformity difference to non-significant levels compared to Novalis. 
The cut-off for realizing a GI of 3, characterizing a sharp dose fall-off 
outside the target volume was achieved for 4cm3 on Novalis and for 
7cm3 with the Vero using DCA technique. Using non-coplanar IMRT, 
this threshold was reduced to 3cm3 for the Vero system. 
Conclusions: The smaller MLC and the presence of the vertex fields 
allow the Novalis system to better conform the dose around the lesion 
and to obtain steeper dose fall-off outside the lesion. However, 
comparable dose dosimetric characteristics can be achieved on Vero 
for lesions larger then 3cm3 and using IMRT.  
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Purpose/Objective: When Elekta CMS XiO TPS was improved (v.4.62) 
with an additional segmentation method for IMRT planning, Smart 
Sequencing (SS), we realized that the shape and delivery sequence of 
the segments produce by this method were considerably different 
from the ones produced with the other available method, Sliding-
Window (SW). The purpose of this work was to study this new 
segmentation method by comparing the plans produced with this 
option (SS plans) to the one we had before (SW plans), for a group of 
selected prostate patients. We evaluated the impact both on the 
achieved dose distributions and QA results. 
Materials and Methods: We selected a group of IMRT prostate 
patients and evaluated 2 typical situations in our department: 
patients treating only prostate and seminal vesicles (Type 1) and 
patients treating also pelvic nodes (Type 2). We used the CMS XiO 
(v.4.62) TPS to calculate alternative IMRT plans (SW vs. SS), both 
calculated using the same dose constraints for target volumes and 
organs at risk and distribution of fields. The plans were produced to 
be delivered in Siemens PRIMUS linear accelerator with 6 or 18 MV 
beams. The plans were compared analysing DVH for the target and 
organs at risks, according to ICRU 83 recommendations. The impact on 
IMRT QA was evaluated comparing point dose measurements, with an 
ion chamber, and plane dose distributions, using a 2D array. We 
compared measured vs. calculated dose to a point in the phantom, 
and gamma parameters such as mean gamma value and gamma 
passing rate. 
Results: For Type 1 cases, we were able to produce plans with 
equivalent dose distributions to PTV and OARs using both 
segmentation methods but, for all cases, using de SS method resulted 
in plans with a reduced number of segments and MUs, and thus 
reduced delivery times. The QA results were considered equivalent 
and all patients were treated with the plans produced with the SS 
methods manly because of the reduced delivery time. 
For Type 2 cases, although SS plans resulted in a reduced number of 
segments and MUs, the SW plans always resulted in better dose 
distributions, namely in terms of OARs sparing. All patients were 
treated with these plans. No significant differences were found in 
terms of IMRT QA. 
Conclusions: When treating regular target volumes, such as most 
prostate tumours (Type 1), the use of Smart Sequencing (SS) 
segmentation method resulted in dose distributions equivalent or 
better than those achieved with the Sliding Window (SW) method, 
always with reduced number of segments and MU. The associated 
reduction in the delivery time will eventually allow us to treat more 
prostate patients with IMRT. 
